In light of recent patient deaths, the FDA has also revoked its platform designation for Sarepta’s AAVrh74 technology. The ...

Sarepta has refused to suspend all dosing of its gene therapy for Duchenne muscular dystrophy, Elevidys, defying a clinical ...

FTSE 100 Live Monday Review calls for Ofwat overhaul Higher fares lift Ryanair profitBP appoints new chair ...

A recent briefing from the Public Health Communication Centre finds that, based on hospitalisation rates, campylobacter ...

By Hugo Francisco de Souza Scientists uncover how zebrafish switch between cell division and direct differentiation to ...

In a stipulation included in a Joint Motion for Entry of Consent Judgment, the IRS stated that when a church communicates ...